Lobbyists: What a disappointment in Congress and Obama

The public is not wrong. The administration’s legislative deals with the pharmaceutical companies were made in back rooms. Business Week reported in early August that the UnitedHealth Group and its fellow insurance giants had already quietly rounded up moderate Democrats in the House to block any public health care option that would compete with them for business. UnitedHealth’s hired Beltway gunslingers include both Elmendorf Strategies and Daschle, a public supporter of the public option who nonetheless does some of his “wink, wink” counseling for UnitedHealth. The company’s in-house lobbyist is a former chief of staff to Steny Hoyer, the House majority leader. Gephardt consults there too.

-Frank Rich, The New York Times